Advertisement

Topics

M Pharmaceutical, Inc.: M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services to Develop Regulatory Strategy for Recently Patented Extrinsa for the Treatment of Female Sexual Dysfunction

07:09 EDT 2 Jun 2017 | FinanzNachrichten

CINCINNATI, OH / ACCESSWIRE / June 2, 2017 / M Pharmaceutical Inc. (CSE: MQ, OTCQB: MPHMF, FWB: T3F2), (the "Company" or "M Pharma"), is pleased to announce that it has engaged Camargo Pharmaceutic...

Original Article: M Pharmaceutical, Inc.: M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services to Develop Regulatory Strategy for Recently Patented Extrinsa for the Treatment of Female Sexual Dysfunction

NEXT ARTICLE

More From BioPortfolio on "M Pharmaceutical, Inc.: M Pharmaceutical Inc. Engages Camargo Pharmaceutical Services to Develop Regulatory Strategy for Recently Patented Extrinsa for the Treatment of Female Sexual Dysfunction"

Quick Search
Advertisement